Surgical versus medical treatment for abnormal uterine bleeding in premenopausal wome
Not Applicable
- Conditions
- Abnormal uterine bleeding.Other specified abnormal uterine and vaginal bleeding
- Registration Number
- IRCT201103065563N3
- Lead Sponsor
- Vice Chancellor for Research, Tabriz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 97
Inclusion Criteria
Premenopausal women between 40-55 years old with abnormal uterine bleeding for at least 2 months which is described as bleeding more than 7 days in a month or heavy bleeding resulting in anemia (Hct<32%), no evidence for atypical heperplasia or carcinoma in D&C, no response to simple medications such as medroxy progetrone and contraceptive tablets, no Ovarian or uterine organic lesions (ruled out by using clinical examination and ultrasonography)
Exclusion criteria: Anemia for other reasons, Fertility preservation, Evidence of pregnancy, Endocrinopathy, Coagulopathy, contraindications for medical treatment, Using IUD
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method terine bleeding. Timepoint: before intervention, 2, 3 months and 2 years after intervention. Method of measurement: asking from patient.
- Secondary Outcome Measures
Name Time Method Anemia. Timepoint: before intervention, 2, 3 months and 2 years after intervention. Method of measurement: Hb and Hct analysis.;Quality of life. Timepoint: before intervention, 2, 3 months and 2 years after intervention. Method of measurement: WHOOQL standard questionaire.